Suggestions
Ron DePinho MD
American physician and research scientist
Ron DePinho is a prominent physician-scientist and cancer researcher currently serving as Professor in the Department of Cancer Biology at MD Anderson Cancer Center, where he holds the Harry Graves Burkhart III Distinguished University Chair in Cancer Biology.23
Key points about Dr. DePinho's career and background:
Education and Early Career
- He received his M.D. from Albert Einstein College of Medicine in 1981.12
- He held faculty positions at Albert Einstein College of Medicine from 1988 to 1998.2
- From 1998 to 2011, he was a Professor of Medicine (Genetics) at Harvard Medical School.12
Leadership Roles
- He served as the fourth president of MD Anderson Cancer Center from 2011 to 2017.14
- During his presidency, he launched initiatives like the Cancer Moon Shots Program and expanded MD Anderson's global network.24
- Prior to MD Anderson, he was Director of the Belfer Institute for Applied Cancer Science at Dana-Farber Cancer Institute from 2004 to 2011.2
Research and Achievements
- Dr. DePinho is internationally recognized for his groundbreaking discoveries in cancer, aging, and age-associated degenerative disorders.25
- His research focuses on pathways governing aging and age-related disorders, particularly cancer.3
- He has published over 400 peer-reviewed articles and is a member of prestigious institutions like the National Academy of Medicine and National Academy of Sciences.14
Current Work
- Since March 2017, he has been a Professor in the Department of Cancer Biology at MD Anderson, continuing his research and mentoring work.23
- He is involved in biotechnology ventures and serves as an advisor for various organizations in the cancer research field.5
Dr. DePinho's work has significantly contributed to the understanding of cancer biology and the development of new approaches to cancer treatment and prevention.
Highlights
A good soul whose voice filled the hearts of many with love
2022 saw new technological marvels and treatment advances, which include RNA nanoparticles that modify the tumor microenvironment of liver cancers; a blood test that can detect early tumors using exosomes containing tumor proteins; CAR T cell treatment for solid tumors; and much more. Take a look at my choice of highlights for last year's cancer research. #cancerresearch
